A higher risk of thrombosis has been described as a prominent feature of coronavirus
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …

Abstract The Korean National Health Information Database (NHID) contains nationwide
claims data, including sociodemographic data, health care utilization, health screening data …

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general
population. The Korean Heart Rhythm Society organized a Korean AF Management …

Background Whether four direct oral anticoagulants (DOACs) are superior to warfarin in
Asian patients with nonvalvular atrial fibrillation (NVAF) remains unclear. Methods This …

Background Dose adjustment of non‐vitamin K antagonist oral anticoagulants (NOAC s) is
indicated in some patients with atrial fibrillation (AF), based on selected patient factors or …

Objective To evaluate the relative efficacy and safety of different oral anticoagulant agents
(OACs) for patients with atrial fibrillation (AF) and chronic kidney disease (CKD). Study …

Modern anticoagulation therapy has dramatically reduced the risk of stroke and systemic
thromboembolism in people with atrial fibrillation (AF). However, AF still impairs quality of …

Background Data on different direct oral anticoagulants (DOACs) in atrial fibrillation (AF)
patients with renal impairment are insufficient. We aimed to perform pairwise and network …

Background Although randomized trials provide a high level of evidence regarding the
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …

Background Whether four direct oral anticoagulants (DOACs) are superior to warfarin
among Asians with non-valvular atrial fibrillation (NVAF) remains unclear in the real-world …